Tag Archives: public policy

Propel Small Business Innovation through Tax Reform

Jeffery_Hatfield copy

As CEO of an emerging clinical-stage biotech company, I lose over $10 million each year. Over the lifetime of my company, I have lost over $100 million. But constantly losing money in an effort to advance discoveries should not overshadow the real lifeblood of biotechnology, which is the reward of seeing patients treated, lives saved, and families healed. Some of the biggest challenges companies like mine face include high research and production costs, coupled with Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

How the Orphan Drug Tax Credit Leverages MDA’s Fight against Rare Genetic Diseases

dna_peoplefigures

In the early 1950s, a small group of concerned parents, people with muscular dystrophy and their friends started a volunteer organization, the Muscular Dystrophy Association (MDA), to raise money for research into the causes of rare genetic diseases that mysteriously destroyed muscles and shortened lives. In the decades since — thanks to the support of a caring public and vital corporate partnerships — MDA has become a leading voluntary health agency, funding research in academic Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

TPP and Innovation in the Bioeconomy: The Need for 12 Years of Data Protection

BIO Logo Horizontal 4C copy

A few weeks ago, BIO submitted a letter and white paper (PDF) to the U.S. Trade Representative outlining recommendations for policies to pursue with TPP negotiating partners to ensure intellectual property protection for innovative biologic products. Standards that enable biotechnology companies to protect and leverage their intellectual property are of critical importance to companies seeking breakthrough treatments and cures for patients in need worldwide. Implementing standards of protection that effectively protect innovation for biological products within the TPP region Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , ,

NORD Urges Congress: Don’t Cut Orphan Drug Tax Credit

patient

This week, the National Organization of Rare Disorders (NORD) and more than 70 patient organizations sent a letter to key members of Congress in support of maintaining the Orphan Drug Tax Credit. Representing millions of American men, women and children suffering from rare diseases, the organizations voice strong support for the Orphan Drug Tax Credit (ODTC) and urge Congress to keep this critical tax credit in place as tax reform proposals are developed. According to Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

The Hill: Innovation-focused tax reform for U.S. global competitiveness

DC in Fall

The Hill Blog published an op-ed by Geoff Davis on ‘Innovation-focused tax reform for U.S. global competitiveness.’ Davis, a former member of the House Ways & Means Committee, which has responsibility for writing our nation’s tax laws,  urges policymakers to support innovative, research-intensive businesses by encouraging private investment as they move towards tax reform. As he states, “If the U.S. is to remain competitive in the global economy, we need to make sure there are policies Read More >

Business and Investments, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , ,